Molecular Characterization of WCK 5222 (Cefepime/Zidebactam)-Resistant Mutants Developed from a Carbapenem-Resistant Pseudomonas aeruginosa Clinical Isolate

WCK 5222 (cefepime/zidebactam) is a β-lactam/β-lactamase inhibitor combination that is effective against a broad range of highly drug-resistant bacterial pathogens, including those producing metallo-β-lactamase. In this study, we isolated a multidrug-resistant Pseudomonas aeruginosa clinical strain...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Xiaolei, Zhao, Xinrui, Song, Yuqin, Ren, Huan, Tian, Zhenyang, Liang, Qi’an, Jin, Yongxin, Bai, Fang, Cheng, Zhihui, Feng, Jie, Wu, Weihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865557/
https://www.ncbi.nlm.nih.gov/pubmed/35196805
http://dx.doi.org/10.1128/spectrum.02678-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865557/
https://www.ncbi.nlm.nih.gov/pubmed/35196805
http://dx.doi.org/10.1128/spectrum.02678-21

Ejemplares similares